- Home
- KG vs HRTX Comparison
KG vs HRTX Comparison
Compare KG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- HRTX
- Stock Information
- Founded
- KG N/A
- HRTX 1983
- Country
- KG Bermuda
- HRTX United States
- Employees
- KG N/A
- HRTX N/A
- Industry
- KG Property-Casualty Insurers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- KG Finance
- HRTX Health Care
- Exchange
- KG Nasdaq
- HRTX Nasdaq
- Market Cap
- KG 225.0M
- HRTX 203.5M
- IPO Year
- KG N/A
- HRTX 1987
- Fundamental
- Price
- KG $14.35
- HRTX $1.11
- Analyst Decision
- KG
- HRTX Strong Buy
- Analyst Count
- KG 0
- HRTX 2
- Target Price
- KG N/A
- HRTX $4.50
- AVG Volume (30 Days)
- KG 17.2K
- HRTX 2.1M
- Earning Date
- KG 11-05-2025
- HRTX 11-04-2025
- Dividend Yield
- KG N/A
- HRTX N/A
- EPS Growth
- KG N/A
- HRTX N/A
- EPS
- KG 8.50
- HRTX N/A
- Revenue
- KG $26,676,137.00
- HRTX $155,097,000.00
- Revenue This Year
- KG N/A
- HRTX $10.62
- Revenue Next Year
- KG N/A
- HRTX $12.99
- P/E Ratio
- KG $1.71
- HRTX N/A
- Revenue Growth
- KG 1610.20
- HRTX 12.60
- 52 Week Low
- KG $13.97
- HRTX $1.04
- 52 Week High
- KG $36.80
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- KG 20.39
- HRTX 39.29
- Support Level
- KG $15.85
- HRTX $1.09
- Resistance Level
- KG $23.89
- HRTX $1.14
- Average True Range (ATR)
- KG 1.62
- HRTX 0.07
- MACD
- KG -0.62
- HRTX 0.00
- Stochastic Oscillator
- KG 1.15
- HRTX 27.08
About KG Kestrel Group Ltd.
Kestrel Group Ltd is specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.